The competent authority has recently published a note (CA-March25-Doc.4.9) aimed at clarifying the application of Article 19(4) of the BPR to products classified as endocrine disruptors (ED) Category 1 and Category 2.
On March 24, 2025, ECHA published the updated list of active substance – product-type (AS-PT) combinations that can be used in treated articles.
Regulation (EU) 2023/2055, which introduces the Restriction of microplastics intentionally added to products, was published in the Official Journal of the European Union on September 25, 2023.
On 27 May ECHA will hold a webinar to introduce the new section of the new Classification and Labelling Inventory (C&L Inventory) now available on the ECHA CHEM database.
The European Chemicals Agency (ECHA) is strengthening chemical safety in the EU through new restrictions and updated guidelines
TEAM mastery will take part in ChemConnect important event for the Italian chemical industry, held in Milan on May 13–14, 2025.
On 3 April 2025, the European Commission presented its proposed changes to the REACH Regulation to national experts during a CARACAL meeting.
The BPC approved the renewal of Dazomet and IPBC for PT8 and issued several opinions in support of Union authorizations for biocidal products
The Ministry of Health granted a derogatory authorization for the marketing and use of disinfectants for intact skin prior to medical treatment containing 2% Chlorhexidine Digluconate
On February 25, 2025, ECHA launched a public consultation on ethanol (CAS: 64-17-5, EC: 200-578-6) as a candidate for substitution in the following applications: